HB Wealth Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.71M | Sell |
23,957
-4,204
| -15% | -$1.7M | 0.08% | 136 |
|
|
2025
Q1 | $14M | Buy |
28,161
+15,134
| +116% | +$7.53M | 0.12% | 104 |
|
|
2024
Q4 | $6.78M | Buy |
13,027
+256
| +2% | +$133K | 0.07% | 134 |
|
|
2024
Q3 | $7.9M | Buy |
12,771
+1,210
| +10% | +$748K | 0.08% | 113 |
|
|
2024
Q2 | $6.39M | Buy |
11,561
+1,649
| +17% | +$912K | 0.07% | 128 |
|
|
2024
Q1 | $5.76M | Buy |
9,912
+1,255
| +14% | +$729K | 0.07% | 138 |
|
|
2023
Q4 | $4.6M | Buy |
8,657
+1,420
| +20% | +$754K | 0.07% | 142 |
|
|
2023
Q3 | $3.66M | Buy |
7,237
+243
| +3% | +$123K | 0.06% | 152 |
|
|
2023
Q2 | $3.65M | Sell |
6,994
-396
| -5% | -$207K | 0.06% | 151 |
|
|
2023
Q1 | $4.26M | Buy |
7,390
+233
| +3% | +$134K | 0.07% | 135 |
|
|
2022
Q4 | $3.94M | Buy |
7,157
+1,978
| +38% | +$1.09M | 0.07% | 137 |
|
|
2022
Q3 | $2.63M | Buy |
5,179
+81
| +2% | +$41.1K | 0.06% | 151 |
|
|
2022
Q2 | $2.77M | Buy |
5,098
+840
| +20% | +$456K | 0.06% | 147 |
|
|
2022
Q1 | $2.52M | Buy |
4,258
+579
| +16% | +$342K | 0.05% | 159 |
|
|
2021
Q4 | $2.46M | Buy |
+3,679
| New | +$2.46M | 0.05% | 145 |
|